For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

One of the ways diabetes can affect the body is by overstimulating the sweat glands. Because of this, it's harder to maintain a steady internal body temperature. Extreme fluctuations in blood sugar ...

The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...

Novo Nordisk (CSE:NOVOb) (NYSE:NVO) shares slumped Wednesday after Roche (SIX:ROG) struck a $5.3 billion deal to acquire rights to an obesity treatment from Denmark’s Zealand Pharma A/S (CSE:ZELA).